Theriva Biologics, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
Theriva Biologics, Inc. (TOVX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $80.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $80.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $26.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $24.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $29.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2025-12-31 | $80.00K 10-K · filed 2026-03-12 |
| 2024-12-31 | $26.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $24.00K 10-K · filed 2025-03-06 |
| 2022-12-31 | $29.00K 10-K · filed 2024-03-25 |
| 2021-12-31 | $27.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $42.00K 10-K · filed 2022-03-16 |
| 2019-12-31 | $20.00K 10-K · filed 2021-03-04 |
| 2018-12-31 | $38.00K 10-K · filed 2020-02-20 |
| 2017-12-31 | $164.00K 10-K · filed 2019-02-27 |
| 2016-12-31 | $119.00K 10-K · filed 2018-02-22 |
| 2015-12-31 | $105.00K 10-K · filed 2017-03-02 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |